NCT05035693 Post Market Clinical Follow up Study With the Cervical Disc Prothesis MOVE®-C
| NCT ID | NCT05035693 |
| Status | Recruiting |
| Phase | — |
| Sponsor | NGMedical GmbH |
| Condition | Discopathy |
| Study Type | INTERVENTIONAL |
| Enrollment | 170 participants |
| Start Date | 2021-03-11 |
| Primary Completion | 2025-03-11 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Study design: International, prospective, multicentre, non-randomised, observational study according to § 23b MPG. Objectives: Observational study to confirm the safety and performance of the cervical disc prosthesis MOVE®-C.
Eligibility Criteria
Inclusion Criteria: 1. Diagnosis of discopathy or disc hernia with radiculopathy or stenosis of the foramen and spinal canal, 2. documented individual history of neck and/or upper extremity pain and/or functional/neurological deficit associated with the cervical level to be treated, 3. no surgical treatment regarding the planned index surgery within the last six weeks prior implantation, 4. unsuccessful conservative medical care regarding the indication within the last six weeks, 5. age ≥18 years, 6. patient must agree to fully participate in the clinical trial and give informed consent in writing, 7. patient is capable to realise the nature, aims and possible consequences of the clinical trial (MPG §20.2.1), 8. patient information has been provided and all written consents of the patient are available. Exclusion Criteria: * Known contraindication against the use of cervical intervertebral disc prostheses in accordance with the manufacturer's instructions for use: 1. Bone mineral densi